Anti-TROVE2 Antibody Determined by Immune-Related Array May Serve as a Predictive Marker for Adalimumab Immunogenicity and Effectiveness in RA

Anti-drug antibody (ADAb) development is associated with secondary therapeutic failure in biologic-treated rheumatoid arthritis (RA) patients. With a treat-to-target goal, we aimed to identify biomarkers for predicting ADAb development and therapeutic response in adalimumab-treated patients. Three i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Po-Ku, Lan, Joung-Liang, Chen, Yi-Ming, Chen, Hsin-Hua, Chang, Shih-Hsin, Chung, Chia-Min, Rutt, Nurul H., Tan, Ti-Myen, Mamat, Raja Nurashirin Raja, Anuar, Nur Diana, Blackburn, Jonathan M., Chen, Der-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963899/
https://www.ncbi.nlm.nih.gov/pubmed/33763493
http://dx.doi.org/10.1155/2021/6656121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963899/
https://www.ncbi.nlm.nih.gov/pubmed/33763493
http://dx.doi.org/10.1155/2021/6656121

Ejemplares similares